Alzinova AB (publ) (ALZ.ST)

SEK 3.5

(0.0%)

Total Debt Summary of Alzinova AB (publ)

  • Alzinova AB (publ)'s latest annual total debt in 2023 was 800 Thousand SEK , down 0.0% from previous year.
  • Alzinova AB (publ)'s latest quarterly total debt in 2024 Q2 was 800 Thousand SEK , down 0.0% from previous quarter.
  • Alzinova AB (publ) reported annual total debt of 800 Thousand SEK in 2022, down 0.0% from previous year.
  • Alzinova AB (publ) reported annual total debt of 800 Thousand SEK in 2021, down 0.0% from previous year.
  • Alzinova AB (publ) reported quarterly total debt of 800 Thousand SEK for 2024 Q2, down 0.0% from previous quarter.
  • Alzinova AB (publ) reported quarterly total debt of 800 Thousand SEK for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of Alzinova AB (publ) (2023 - 2012)

Historical Annual Total Debt of Alzinova AB (publ) (2023 - 2012)

Year Total Debt Total Debt Growth
2023 800 Thousand SEK 0.0%
2022 800 Thousand SEK 0.0%
2021 800 Thousand SEK 0.0%
2020 800 Thousand SEK 0.0%
2019 800 Thousand SEK 0.0%
2018 800 Thousand SEK 0.0%
2017 800 Thousand SEK 0.0%
2016 800 Thousand SEK 3.87%
2015 770.18 Thousand SEK 92.55%
2014 400 Thousand SEK 0.0%
2013 400 Thousand SEK 0.0%
2012 - SEK 0.0%

Peer Total Debt Comparison of Alzinova AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 95.03%
Ziccum AB (publ) 857 Thousand SEK 6.651%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 83.933%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 96.733%
Genovis AB (publ.) 79.32 Million SEK 98.991%
Intervacc AB (publ) 181 Thousand SEK -341.989%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 96.119%
Active Biotech AB (publ) 3 Million SEK 73.333%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.673%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 84.0%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 98.88%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 89.78%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -88.679%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.263%
Karolinska Development AB (publ) 3.07 Million SEK 73.941%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 68.992%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 20.0%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.918%
Camurus AB (publ) 24.5 Million SEK 96.736%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 97.098%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.908%
Cyxone AB (publ) 858 Thousand SEK 6.76%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 53.244%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 97.827%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -20.12%
SynAct Pharma AB 637 Thousand SEK -25.589%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 5.882%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 54.571%
BioInvent International AB (publ) 23.24 Million SEK 96.558%
Oncopeptides AB (publ) 106.48 Million SEK 99.249%
Pila Pharma AB (publ) 773.08 Thousand SEK -3.482%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.118%
Diamyd Medical AB (publ) 30.67 Million SEK 97.392%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.654%
Ascelia Pharma AB (publ) 1.06 Million SEK 24.599%
Diagonal Bio AB (publ) - SEK -Infinity%